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ing by ElAbstract Purpose: To determine the role of diffusion weighted MR imaging and apparent diffu-
sion coefﬁcient (ADC) in chest wall masses.
Materials and methods: This study included 62 patients with chest wall masses. They underwent
routine MR imaging and diffusion MR weighted imaging on a 1.5 T MR unit (Symphony-Siemens).
Diffusion MR imaging was done with diffusion factor b value of 0, 500, and 1000 s/mm2. The
apparent diffusion coefﬁcient (ADC) map was reconstructed. The signal intensity was visually
assessed on ADC maps and ADC value was measured in chest wall lesions. The mean ADC values
correlated with histo-pathological results.
Results: Adequate ADC maps were obtained in 62 patients. The mean ADC values of chest wall
lesions were 1.76 ± 0.08 · 103 mm2/s in inﬂammatory lesion, 3.21 ± 0.05 · 103 mm2/s in thed imaging; ADC, apparent
lymphoma.
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148 A. El-Badrawy et al.cystic lesions, 1.67 ± 0.03 · 103 mm2/s in neuroﬁbroma, 2.12 ± 0.07 · 103 in haemangioma, and
0.89 ± 0.06 · 103 mm2/s in malignant tumors. The mean ADC value of the malignant tumor was
signiﬁcantly different from that of benign chest wall tumors (P< 0.001).
Conclusion: Diffusion weighted MR imaging is a new imaging modality for differentiation malig-
nant from benign chest wall masses. In addition, it has a role in characterization of different malig-
nant and benign tumors.
 2011 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
The extent of tissue cellularity and the presence of intact cell
membranes help determine the impedance of water molecule
diffusion. Tissue types that have been reported to be associated
with impeded diffusion include tumor, cytotoxic edema, ab-
scess, and ﬁbrosis. Tissues with low cellularity or that consist
of cells with disrupted membranes permit greater movement
of water molecules (1). Diffusion-weighted imaging has been
primarily limited to the CNS because many technical prob-
lems, mostly related to gross physiologic motion, affect diffu-
sion-weighted imaging (2,3). With the advent of the echo-
planar MR imaging technique, DW MR imaging of the abdo-
men and thoracic cavity has become possible with fast imaging
times, which minimize the effects of gross physiologic motion
from respiration and cardiac movement (4).
The aim of this study is to perform DWI of chest wall
masses and evaluate the role of apparent diffusion coefﬁcient
(ADC) in differentiation of malignant from benign masses
and to characterize masses within each group.2. Materials and methods
2.1. Patients
Our study received institutional review board approval, and all
patients provided informed consent. Between April 2008 and
August 2009, MR imaging studies performed of clinically sus-
pected chest wall masses. The study includes 62 patients (36
males, 26 females). Their age ranged from 2 to 78 years (mean
age, 47 years). The clinical presentations were chest wall swell-
ing (n= 52), pain (n= 39), fever (n= 18), and incidental dis-
covered (n= 8). More than one clinical ﬁnding may occur in
one patient. All patients had undergone CT scanning. The
method of examination was fully explained to patient before
imaging to obtain his consent. They were instructed to remove
ferromagnetic materials. All patients were referred from
Oncology Center Mansoura University.
Pathological conﬁrmation was on the basis of surgical
resection ﬁndings (n= 12), Trucut biopsy (n= 36), ﬁne needle
aspiration cytology (n= 8) and follow up (n= 6). The histo-
logical types are shows in Table 2.
2.2. MRI techniques
All MR examinations were performed in Mansoura University
Hospital, Diagnostic Radiology Department, MRI unit, using
a 1.5 T superconducting unit (Siemens Magnetom Symphony
version, Syngo, MR 2002 A) using body phased-array coil.The machine was equipped with a self-shielding gradient set
(23 mT/m maximum gradient strength and 120 mT/m/s slew
rate). All patients were examined in the supine position
throughout the examination.
MR imaging was performed in axial and coronal planes
with T1 (400–600/15–20 ms TR/TE), T2 true FISP (4.3/
2.1TR/TE, 80 ﬂip angle), HASTE (800/26 ms TR/TE),
6 mm slice thickness, 2 mm slice interval, 350 · 350 mm
FOV, and 256 · 512 matrix). Cardiac gating and respiratory
compensation techniques were routinely used. Contrast-en-
hanced MRI done in 17 patients using gadolinium chelate
(0.2 mmol/kg body weight) at a rate of 2.0 mL/s and then a
20 mL saline ﬂush was delivered into the antecubital vein.
2.3. Diffusion-weighted imaging
It was performed for all patients before injection of contrast
material. Diffusion-weighted images were obtained using a sin-
gle shot echo planar imaging sequence EPI (5000/139 ms TR/
TE, 6 mm slice thickness, 2 mm slice interval, 350 · 350 mm
FOV, and 256 · 512 matrix) with diffusion sensitivities of b
values = 0, 500, and 1000 s/mm2. The diffusion gradient was
applied sequentially in the three orthogonal directions. ADC
map were reconstructed. Scan time was <2 min.
2.4. Image analysis
 Qualitative assessment of DWI and ADC map:
All DW MR images were analyzed. DW MR images
were analyzed qualitatively by focusing on the signal
intensity of the chest wall lesion, which was classiﬁed
by using visual assessment of hypo-, hyperintensity or
mixed signal in comparison with the signal intensity of
adjacent normal skeletal chest wall muscles. The com-
parison of signal intensities on DW MR image among
histologic types of chest wall mass was performed.
The abnormal regions on DWI and ADC map were out-
lined by using the conventional images as a guide. SI of
ADC map assessed visually.
 Quantitative assessment of ADC:
Measurement of ADC was made using an electronic cur-
sor on the ADC map in different regions of interest
(ROI) of the lesions. The region of interest with a diam-
eter of approximately 1.0 cm was positioned for the
measurement of ADC in each mass. The ADC values
were expressed in 103 mm2 /s. Then the mean ADC
value for the lesions was calculated. Attention to direct
the ROI to the solid part of the lesion was paid to avoid
wrong measurement of cystic necrotic tumor part. If
Figure 1 MRI acquired in female patient aged 58 years old presented with chest wall cystic lesion after excision of lipoma. The mass
exhibits low signal on axial T1 W.I. (A) High signal on axial T2 W.I. (B) and High signal on ADC map (C). The ADC value was
3.21 ± 0.06 · 103 mm2/s. The cystic lesion was seroma.
Figure 2 MRI acquired in male patient aged 24 years old presented with incidental discovered chest wall mass. The mass exhibits
isosignal on non-contrast coronal T1 W.I. (A) Mixed signal on axial T2 W.I. (B) and High signal on ADC map. (C) The ADC value was
1.67 ± 0.03 · 103 mm2/s. The mass pathologically proved neuroﬁbroma.
Figure 3 MRI acquired in female patient aged 55 years old
presented with chest wall mass. The mass exhibits mild high signal
on axial T2 W.I. (A) and Low signal on ADC map. (B) The ADC
value was 0.83 ± 0.02 · 103 mm2/s. The mass pathologically
proved NHL.
Figure 4 MRI acquired in male patient aged 68 years old
presented with peripheral bronchogenic carcinoma invading the
chest wall. The mass exhibits mixed signal on axial T2 W.I. (A)
and Mixed signal on ADC map. (B) The ADC value of the solid
part was 0.88 ± 0.07 · 103 mm2/s.
Table 1 Visual assessment of SI on ADC map.
Chest wall mass and ADC 149there seemed to be no necrotic area, the region of inter-
est was placed on the center of the chest wall mass.Lesion Low SI High SI Mixed SI
Benign – 9 1
Inﬂammatory – 5 –
Cystic – 6 –
Malignant 29 2 10
Total 29 22 112.5. Statistical analysis
T test was done to correlate the mean ADC values with path-
ological results. The statistical analysis of data was done using
SPSS program [statistical package for social science version10].
The mean ± SD was used for data description. One way AN-
OVA test was used when compared more than two groups,
independent sample t-test when compare two groups (Table
3). A P value is considered signiﬁcant if 60.05 at conﬁdence
interval 95%.
3. Results
Adequate ADC maps were obtained in all 62 patients. The
ADC map of benign tumors was mainly high SI (9/10). In
other benign lesions, as osteomyelitis and cysts; the ADC mapswere high SI. The malignant tumors were low SI (29/41) and in
10/41; the SI of ADC maps were mixed signal, but mainly low.
The presence of this mixed signal is due cystic degeneration in-
side the malignant tumor.
The mean ADC values in inﬂammatory lesion of the chest
wall were 1.76 ± 0.08 · 103 mm2/s. The mean ADC values
were 3.21 ± 0.05 · 103 mm2/s in the cystic lesions, 1.67 ±
0.03 · 103 mm2/s in neuroﬁbroma, 2.12 ± 0.07 · 103 in
Table 2 Mean ADC value of chest wall lesions.
Pathology No. of patients Mean ADC value (·103 mm2/s)
Benign lesion Total 21 2.16 ± 0.07
Masses Total 10 1.9 ± 0.05
Neuroﬁbroma 6 1.67 ± 0.03
Haemangioma 4 2.12 ± 0.07
Cyst Cyst 6 3.21 ± 0.05
Inﬂammatory Rib osteomyelitis 5 1.76 ± 0.08
Malignant Total 41 0.89 ± 0.06
Metastases 21 0.85 ± 0.08
Plasmacytoma 5 0.95 ± 0.04
NHL 7 0.83 ± 0.02
Ewing’s sarcoma 4 0.94 ± 0.08
Peripheral bronchogenic carcinoma invading chest wall 4 0.88 ± 0.07
Table 3 Statistical results.
Pathology P value
Malignant vs. benign tumors <0.001
Neuroﬁbroma vs. haemangioma <0.001
Inﬂammatory vs. benign masses <0.03
Within malignant group <0.012
Malignant vs. inﬂammatory lesions <0.001
150 A. El-Badrawy et al.haemangioma, and 0.89 ± 0.06 · 103 mm2/s in malignant
tumors (Figs. 1–4). The mean ADC value of the malignant
tumor was signiﬁcantly different from that of benign tumors
(P< 0.001). The ADC maps and ADC values are shown in
Tables 1 and 2.
4. Discussion
DWI is increasingly used for the evaluation of extracranial dis-
eases. There is growing interest in the application of DWI for
the evaluation of the patient with cancer. DWI do not require
the administration of exogenous contrast medium. Thus, these
imaging sequences can be appended to existing imaging proto-
cols without a signiﬁcant increase in the examination time.
Furthermore, DWI yields both qualitative and quantitative
information that can be helpful for tumor assessment (5).
Diffusion-weighted MR imaging is an evolving technology
with the potential to improve tissue characterization when
ﬁndings are interpreted in conjunction with ﬁndings obtained
with other conventional MR imaging sequences (1). However,
DW echo-planar MR imaging is not satisfactory in general be-
cause of problems with susceptibility, fat saturation, and spa-
tial resolution (6).
Diffusion-weighted MRI (DWI) can be used to monitor cel-
lular structures in biological media (7). The ADC value is esti-
mated to be lower in viable tumor tissue with densely packed
diffusion-hindering obstacles than in tissue with less densely
packed obstacles, such as tumor necrosis and benign tissue (8).
Low ADC in biological systems is believed to reﬂect re-
duced mean-squared displacement of water molecules due to
high cell density and proliferation as well as cell swelling in
the tissue (9). Malignant tumors generally possess higher cell
proliferation than benign and normal tissues (10). Enhancedcell density and proliferation of malignant lesions restrain
the motion of water molecules in a reduced extracellular space
and, as a result, decrease the ADC during untreated tumor
growth (9,11,12). On this basis, DWI may aid in differentiating
malignant from benign or normal tissues and facilitate detec-
tion of therapeutic response (10,13). This is in agreement with
our study, as the mean ADC value of malignant tumors was
low. More ever, we found than the more malignant tumors
as metastases, NHL, peripheral bronchogenic carcinoma were
lower ADC values than other malignant tumors as plasmacy-
toma and Ewing’s sarcoma. This coincides with Matoba (6)
who found that the ADCs of well-differentiated adenocarci-
noma appear to be higher than those of other histologic lung
carcinoma types.
DWI differentiates benign from malignant lesions in brain
(14–16), liver (17,18), breast (11,19), and prostate (9,20). We
are in agreement with these studies as the mean ADC value
of malignant tumors was signiﬁcantly lower than that of be-
nign masses (P value <0.001).
On diffusion images, 13/14 patients with benign nodes
showed low signal intensity and had high signal on ADC
maps, whereas all patients with malignant diseases appeared
hyperintense on diffusion images and with low signal intensity
on ADC maps. Only a patient with tuberculosis showed a low
ADC value. The mean ADC value of malignant nodes was
about 0.85 · 103 mm2/s, the mean value of benign nodes
was 1.448 · 103 mm2/s; this difference was statistically signif-
icant (P< 0.01) (21). We are in agreement with this previous
results as in our study, the signal intensity on ADC of benign
lesions was mainly high (20/21) and the signal intensity of
malignant tumor was mainly low (29/41). The mixed signal
of malignant tumors (10/41) was due to areas of necrosis.
There are two malignant tumors with marked necrosis showed
high ADC signal.
Consistent with the preceding study (22), we found that the
ADC values were signiﬁcantly higher in benign cystic lesions
than other lesion. It was 3.21 ± 0.13 · 103 mm2/s.
The mean ADC value of lymphomatous, metastatic and
benign lymph nodes was (0.87 ± 0.17) · 103, (0.98 ± 0.09) ·
103, and (1.20 ± 0.10) · 103 mm2/s. There was signiﬁcant
difference in ADC value between benign lymph nodes and other
two groups (P< 0.01) (23).We are in agreement with this study
in that there was signiﬁcantly difference between benign and
malignant masses (P< 0.001), but there was not difference in
Chest wall mass and ADC 151the value of ADC value of metastases and NHL. This may be
due to the previous study was on lymph nodes and the current
study was on the chest wall.
The advantage of DWI is that it is completely noninvasive,
does not require exposure to ionizing radiation or administra-
tion of exogenous contrast medium and does not cause patient
discomfort. To date, the use of DWI for differentiating differ-
ent malignant chest wall tumors has not been reported. In this
study, we found that the P value within malignant group was
<0.012. The differences in ADC values might reﬂect differ-
ences in histopathologic features: metastases and NHL gener-
ally had enlarged cells and the tumor cellularity seemed to be
relatively high, so its ADC values tended to be lower in our
study. Therefore, it is feasible to use DWI to distinguish metas-
tases and NHL from plasmacytoma and Ewing’s sarcoma and
this technique would be of great beneﬁt to physicians to choose
optimal treatment regimen.
This study has several limitations. Avoiding susceptibility
artifacts on DWI of pulmonary lesions is rather difﬁcult.
Although we use phase array coil with cardiac gating and
respiratory compensation techniques to improve image quality
and speed, artifacts associated with echo-planar imaging se-
quences and macroscopic movement still existed which re-
sulted in image distortion. Fortunately, these artifacts were
not very severe and the images could fulﬁll the requirements
needed to make the diagnosis.
In conclusion, diffusion-weighted MR imaging is a new
imaging modality to predict the histo-pathological differentia-
tion of malignant from benign chest wall masses. In addition,
it has a role in characterization of different malignant and be-
nign tumors. Further studies with more recent advance in dif-
fusion MR technology are recommended to improve the image
quality of chest wall masses.Disclosure
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